Core B, the Data Management and Analysis Core (DMAC) has two primary sets of responsibilities, which may be viewed as specific aims: (a) data management, and (b) data analysis. We have extended the capabilities of Core B to act as a clearinghouse for all clinical, genetic and phenotypic data. In this fashion, Core B will effectively be the centralized group that tracks all data and its sources. The Core is available to the Principal Investigators of the other Cores and Projects for: (a) obtaining human specimens, including both DMA (blood) and surgical tissue specimens;(b) obtaining associated clinical, demographic and detailed phenotypic data associated with specimens;(c) managing and checking the flow of information into the database resources of Core B;and (d) providing datasets for statistical analysis and support. This core structure will allow for optimal coordination of the clinical and basic science research programs by providing a single centralized resource. All projects and Core C monitor and select what samples and/or data may be available for their use. Projects will use Core B to arrange obtaining specimens from either the UCSF DMA bank or the Core C surgical tissue bank. Data analysis includes biostatistical data analysis, data cleaning, quality assurance, monitoring patient recruitment and retention, and preparation of interim reports. Optimal biostatistical analysis also includes involvement in experimental design issues. Core B will also assist in preparation of manuscripts and presentations.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS044155-10
Application #
8451442
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
Budget Start
2013-04-01
Budget End
2014-03-31
Support Year
10
Fiscal Year
2013
Total Cost
$259,078
Indirect Cost
$91,462
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Kremer, P H C; Koeleman, B P C; Pawlikowska, L et al. (2015) Evaluation of genetic risk loci for intracranial aneurysms in sporadic arteriovenous malformations of the brain. J Neurol Neurosurg Psychiatry 86:524-9
Choi, Eun-Jung; Chen, Wanqiu; Jun, Kristine et al. (2014) Novel brain arteriovenous malformation mouse models for type 1 hereditary hemorrhagic telangiectasia. PLoS One 9:e88511
Han, Zhenying; Shen, Fanxia; He, Yue et al. (2014) Activation of ?-7 nicotinic acetylcholine receptor reduces ischemic stroke injury through reduction of pro-inflammatory macrophages and oxidative stress. PLoS One 9:e105711
Wada, Kosuke; Makino, Hiroshi; Shimada, Kenji et al. (2014) Translational research using a mouse model of intracranial aneurysm. Transl Stroke Res 5:248-51
Bendjilali, Nasrine; Nelson, Jeffrey; Weinsheimer, Shantel et al. (2014) Common variants on 9p21.3 are associated with brain arteriovenous malformations with accompanying arterial aneurysms. J Neurol Neurosurg Psychiatry 85:1280-3
Chen, Wanqiu; Young, William L; Su, Hua (2014) Induction of brain arteriovenous malformation in the adult mouse. Methods Mol Biol 1135:309-16
Rutledge, W Caleb; Ko, Nerissa U; Lawton, Michael T et al. (2014) Hemorrhage rates and risk factors in the natural history course of brain arteriovenous malformations. Transl Stroke Res 5:538-42
Takayanagi, Takehiko; Crawford, Kevin J; Kobayashi, Tomonori et al. (2014) Caveolin 1 is critical for abdominal aortic aneurysm formation induced by angiotensin II and inhibition of lysyl oxidase. Clin Sci (Lond) 126:785-94
Tada, Yoshiteru; Wada, Kosuke; Shimada, Kenji et al. (2014) Roles of hypertension in the rupture of intracranial aneurysms. Stroke 45:579-86
Sallach, Jessica; Di Pasquale, Giovanni; Larcher, Fernando et al. (2014) Tropism-modified AAV vectors overcome barriers to successful cutaneous therapy. Mol Ther 22:929-39

Showing the most recent 10 out of 94 publications